Electronic Medical Records Market - Market Analysis Report, 2015 - 2023

An electronic medical record is a digital version of paper-based medical information of patients. Such electronic medical records are aimed at improving the overall quality of care. Electronic medical record comprises combination of clinical, financial, demographic and coded healthcare data. Many government organizations have also stressed upon the significance of electronic medical records. For instance, according to the World Health Organization, the proper collection, management and use of information within healthcare systems will determine the system’s effectiveness in detecting health problems, defining priorities, identifying innovative solutions and allocating resources to improve health outcomes. Currently, a number of hospitals and clinics are using electronic medical records to store important documents related to the patient’s illness. The information repository of individual patients would lead to better security and quick data retrieval whenever required.

Read Full Report: http://www.transparencymarketresearch.com/electronic-medical-records-market.html

Based on software delivery mode, the electronic medical records market can be segmented as follows:
Cloud: Cloud computing software allows centralized data storage and online access to services with multiple sites across geographic locations but do not support remote access to existing network. The software possesses the flexibility to allow anywhere and anytime access of data records.
On-premise: On-premises software, also known as shrink wrap, is installed and operated from the premises of the person or any organization. It makes use of the organization’s local computing resources and requires a licensed software copy from an independent software vendor
Based on end users, the electronic medical recordsmarket can be segmented as follows:
Hospitals
Clinics and nursing homes
Home health agencies

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6526

Geographically, the electronic medical recordsmarket can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Out of these four regions, North America holds a leading position in the market followed by Europe. The prime factors driving the growth of the electronic medical recordsmarket in these regions are increased portability and accessibility of medical document management systems, and growing demand for paperless environment to minimize human error. Furthermore, technological advancement and modernization in the healthcare management system and improved clinical studies are also expected to augment the growth of the electronic medical records market in North America and Europe. Asia Pacific is one of the fastest growing regions globally and is expected to emerge as the most promising market for the growth of the electronic medical records market. The factors which would boost the growth of the market in Asia Pacific are growing demand for better quality of care, and increasing government initiatives to opt for patient flow management solution and electronic health records (EHRs). Moreover, better management of patient’s information record and increasing need to minimize records retention costs is also expected to accentuate the growth of the electronic medical recordsmarket in Asia Pacific.

Various companies offer novel systems and software for the management of health information. Such companies have simplified the complex medical records, hence achieving quality outcomes. Some of the top companies operating in the electronic medical recordsmarket are 3M Company, Toshiba Medical Systems Corp., Hyland Software, Siemens Medical Solutions, McKesson Corporation, Henry Schein, Inc., Allscripts Healthcare Solutions, Inc., WRS Health, Medical Information Technology, Inc. (Meditech), Cerner Corporation,Quest Diagnostics, GE Healthcare, Epic Systems, SequelMed, Kofax Limited and others. 

Extracorporeal Shock Wave Lithotripsy Market - Global Industry Analysis, Trends And Forecast 2015 - 2023

Extracorporeal shock wave lithotripsy (ESWL) is a most common non-invasive treatment for kidney stones and ureter stones. The lithotriptor applies external high-intensity acoustic pulse to crush the stone causing minimal damage to the normal tissue. The shock waves break the stones into small fragments. ESWL is widely used by physician worldwide due to characteristics such as non-invasiveness, reduced pain and recovery time and reduced hospital stay. The developing health care infrastructure by and availability of technically developed equipment to carry out the procedure are the vital drivers for the extracorporeal shock wave lithotripsy market. In addition, the rising prevalence and incidences of kidney stones and ureter stones are expected to fuel the extracorporeal shock wave lithotripsy market. Furthermore, the rising prevalence of obesity and patient awareness about the latest technological advancements will contribute to the growth of the market. However, failure of crushing large stones through ESWL is the challenging factor for the extracorporeal shock wave lithotripsy market.

Read Full Report: http://www.transparencymarketresearch.com/extracorporeal-shock-wave-lithotripsy-market.html

The extracorporeal shock wave lithotripsy market can be segmented into technological, applications and end-user. Technologically, the market can be further segmented into electrohydraulic technique, piezoelectric technique, and electromagnetic technique. Electrohydraulic technique is the oldest and the original method of shockwave generation. Thus, it hold the largest share and is the most accepted technique in the extracorporeal shock wave lithotripsy by physicians and doctors. However, piezoelectric technique has the highest growth rate during the forecast period. On the basis of applications, the extracorporeal shock wave lithotripsy is used for kidney stones, uretic stones, pancreatic stones and salivary stones. Extracorporeal shock wave lithotripsy for kidney has the largest market share and continue to show uniform growth during the forecast period. Depending on the end-user, extracorporeal shock wave lithotripsy is segmented into hospitals, clinics, radiology labs and others. Hospitals held the largest share in the extracorporeal shock wave lithotripsy market by end-user. However, the growth of clinic providing extracorporeal shock wave lithotripsy is boosting due to technological growth and reduced recovery time and early discharge after the treatment.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6523

Geographically, North America held the largest share in the extracorporeal shock wave lithotripsy throughout the forecast period. Presence of large number of obese patients susceptible to the development of kidney stones is expected to surge the market. Investment in medical device technology research and development have coursed in the recent past as well as collaborations have led to recent advances in the technique. Europe is the second largest extracorporeal shock wave lithotripsy market due to increased government investment fueling the market growth. However, the fastest growing region is expected to be Asia Pacific due to emerging health care infrastructure, and development of technological facilities. Rising population, changing lifestyle and high acceptance to novel technology are the major market drivers in this region. Japan, China and India are the fastest growing economies in Asia Pacific. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, and high disposable income. 
Globally, the extracorporeal shock wave lithotripsy market is dominated by players such as Boston Scientific Corporation, C.R. Bard Inc., Lumenis LTD, Cook Group Inc., Siemens AG, Medtrue Enterprise Co. Ltd., Karl Storz Gmbh and Co. KG, Olympus Corporation, Sainty Pharma, and Dornier MedTech GmbH.

Read More Report on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Leukemia Therapeutics Market - Industry Research Report, 2015 - 2023

Leukemia is a type of blood cancer resulting in the abnormal production of blood cells, generally leukocytes (white blood cells). These abnormal cells crowd the bone marrow and other organs such as liver, spleen, and kidneys through blood and prevent its normal functions. There are several types of leukemia that appear suddenly and progress rapidly over days to weeks. Others are less apparent and progress slowly over months to years. Leukemia are named according to the type of blood cells involved. The myeloid leukemia are the ones which involve the granulocytes, red blood cells, platelets, and monocytes and lymphocytic leukemia are those which involve lymphocytes. Leukemia is commonly caused due to the high exposure to radiations, unhealthy lifestyle, genetic factors, and environmental conditions. Leukemia cases are more common in adults and are observed to progress with aging. Thus, increasing geriatric population base and high prevalence of leukemia are the factors driving the leukemia therapeutic market. Moreover, increased innovation and R&D in the oncology sectors and growing number of biotechnology firms are also expected to propel the market growth. Increasing awareness of patients regarding most recent technological developments, introduction of novel therapies and promising pipeline products are the factors expected to further drive the market growth during the forecast period. However, high cost of drugs and treatments along with large number of entry-to-market barriers are some of the challenges faced by the leukemia therapeutic market.

Browse Full Report: http://www.transparencymarketresearch.com/leukemia-therapeutics-market.html

Leukemia therapeutics market can be segmented on the basis of the disease condition, treatment and drugs. Leukemia therapeutic market includes disease such as acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Chronic myeloid leukemia dominated the overall leukemia therapeutic market owing to high prevalence rate in 2014. Treatment segment includes chemotherapy, radiation therapy, immunotherapy, surgery, targeted therapy, bone marrow transplant, and stem cell therapy. Radiation therapy and chemotherapy treatments were the most popularly used methods for the treatment of leukemia. Chemotherapy is the standard treatment for many types of leukemia. Targeted therapies are a newer forms of cancer treatment that can be used together with chemotherapy or unavailability of other therapies. Stem cell therapy and bone marrow transplant are the emerging trends in leukemia therapeutic market and are expected to boost the market growth. Drugs used for treating leukemia can be classified according to the classes which include kinase inhibiting drugs such as imatinib (Gleevec), dasanib (Sprycel), erlotinib (Tarceva), and gefitinib (Iressa); aminopeptidase inhibitors like Tosedostat; and immunomodulatory drug class (IMiDs) such as lenalidomide (Revlimid) and others. Sapacitabine, GA101 (Obinutuzunab), fludarabine and cyclophosphamide are some promising drugs in the clinical trials.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6487

Geographically, North America accounts for the largest regional market, followed by Europe due to the increasing patient awareness, technological advancement, supportive government policies in terms of incentives and investments, and refined healthcare infrastructure. According to the World Health Organization (WHO), leukemia is expected to be more prominent in the developed world such as North America and Europe due to genetic factors caused by enhanced radiation exposure. Environmental factors and unhealthy lifestyles are the factors which add to the count. Similarly, the market is expected to grow promptly due to presence of high unmet needs in the emerging countries of Asia Pacific such as China, India, and Japan. Increasing investments in R&D expenditures by biotechnology firms, rapidly improving health care infrastructure, and growing awareness levels are the factors promoting the market growth in Asia Pacific. Countries of South America countries such as Brazil and Mexico are expected to have significant growth potential due to developing medical infrastructure, high disposable income, and rising prevalence of leukemia.
Some of the prominent market players operating in the global leukemia therapeutics market are Novartis AG, F. Hoffmann-La Roche AG, Bristol Myers Squibb Company (BMS), GlaxoSmithKline plc, Pfizer, Inc., Celgene Corporation, Biogen, Genzyme Corporation, and Eisai Co. Ltd.

Read More Reports on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Guidewires Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2015 - 2023

A guidewire is a thin and flexible tube used to guide a catheter for placement in the diseased artery. The catheter is advanced through a guidewire into the blood vessel, then guided to aorta and finally, the guidewire is removed. The most frequent insertion point for the guidewire and catheter is the femoral artery at the groin. Apart from this, other possible insertion points for guidewires include brachial artery and coronary arteries. With the increase in the number of minimally invasive procedures, the demand for guidewires is expected to increase in the next few years. Most guidewires are manufactured from low cost stainless steel with an elastic coil tip to avoid damage to the blood vessels. These guidewires are reusable in nature; hence most manufacturers prefer low cost stainless steel as the choice of raw material. A number of companies offer a robust range of tip shapes and wire configurations making it possible for healthcare experts to choose the right tool for surgical procedures. The usage of guidewiresis growing rapidly in the medical device industry due to its biomechanical properties. Additionally, the demand for guidewires is being fueled by rising patient awareness about the benefits of minimally invasive procedures such as less traumatic surgical experience, reduced hospital stay, and faster recovery.

Browse Full Report: http://www.transparencymarketresearch.com/guidewires-market.html

Based on types, the guidewires market has been segmented into the following:
Peripheral guidewire
Coronary guidewire
Neurovascular guidewire
Urology guidewire
Geographically, the guidewires market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America holds a leading position in the guidewires market followed by Europe. The major driving factors for the growth of the guidewires market in these regions arerise in geriatric population, and growing lifestyle diseases. Additionally, increasing demand for minimally invasive surgeries, unique biomechanical properties of guidewires, and growing inclination of healthcare professionals toward the usage of efficient medical devices are some of the factors expected to drive the market growth during the forecast period. Hence, all these factors are collectively driving the demand for medical guidewires. Asia Pacific is one of the most lucrative markets for the growth of guidewires market and is developing at a rapid rate. The factors which would accentuate the growth this market in Asia Pacific are presence of a large pool of patients suffering from peripheral vascular diseases which would consequently lead to an increase in the volume of endovascular procedures in densely populated countries such as India and China. Furthermore, economic development, improving healthcare facilitiesrising disposable incomes, and government initiatives in countries such as China and Indiaprovide a large base of patient population with access to healthcare facilities at an affordable rate.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6484

Various medical devices companies are constantly trying to come up with novel guidewires for different medical procedures. Technological innovation and advancements across various type of guidewires, in terms of flexibility, construction, and tip retention are few of the factors to be considered while manufacturing medical guidewires. Some of the top major players operating in the guidewires market are Boston Scientific Corporation, Cordis Corporation, C.R. Bard, Inc., ASAHI INTECC, Terumo Corporation, Covidienplc, Medtronic, Inc., Abbott Laboratories, B. Braun Melsungen AG, and Cook Medical.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of 
Market growth drivers 
Factors limiting market growth
Current market trends 
Market structure
Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Report on Medical Devices Market: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

According to a new market report published by Transparency Market Research “Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”, the global cell culture media, sera, and reagents market was valued at US$3.7 bn in 2014 and is estimated to reach US$7.1 bn by 2023 at a CAGR of 7.6% from 2015 to 2023. 

The cell culture market has been extensively analyzed on the basis of media, sera, and reagents. The cell culture media segment has been sub-segmented into chemically defined, classical, lysogeny broth, protein-free, serum-free, and specialty media. The cell culture sera segment has been sub-segmented into fetal bovine serum, newborn calf and adult bovine serum, and others. The cell culture reagents segment has been sub-segmented into albumin, amino acids, attachment factors, growth factors and cytokines, protease inhibitors, and others. The albumin segment has been further studied for human serum albumin, bovine serum albumin, and recombinant serum albumin. The growth factors and cytokines segment has been studied for insulin-like growth factors, interleukins and interferon, tumor necrosis factors, and other growth factors and cytokines. The other reagents segment has been sub-segmented into porcine trypsin, recombinant trypsin, thrombin, and miscellaneous reagents.

Read Full Report: http://www.transparencymarketresearch.com/cell-culture-media-sera-reagents-market.html

Cell culture media has been identified as the largest segment of the cell culture media, sera, and reagents market in 2014. Cell culture industry experts are of the opinion that end-users seek high quality media that provide both reproducible results as well as robust yields. The adoption of chemically defined media has been slow yet steady for both media manufacturers and bioprocessors. Demand for media has been shifting from serum-based to serum-sparing, serum-free animal derived, and chemically-defined media. Improvements in cell productivity and cell culture have led to the adoption of smaller processes that employ single use equipment. This has increased demand for ready-to-use liquid media and media powders.

Sera provides wide range of macromolecules, trace elements, carrier proteins, spreading factors, hormones, low molecular weight nutrients, and other growth factors. Serum is commonly used as a supplement in cell culture media. Serum in general is an imprecise component of cell culture media, as a number of serum-free media formulations are being developed and introduced in the market. In addition, media without serum or animal derived components are considered ideal for the study of the role and function of small molecule drug candidates.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6598

Cell culture reagents are chemicals that are used to synthesize or detect another substance under study in the culture. Most commonly used reagents are cell dissociation reagents, extracellular attachment matrices, cell freezing media, cell washing solutions, growth factors, amino acids and other related products.

Browse the full Press Release of Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/pressrelease/cell-culture-media-sera-reagents-market.htm

The global cell culture media, sera, and reagents market has been segmented as given below:
Global Cell Culture Media Market Revenue, by Type
Chemically defined
Classical
Lysogeny broth (LB)
Protein-free
Serum-free
Specialty
Global Cell Culture Sera Market Revenue, by Type
Fetal Bovine
Newborn Calf and Adult Bovine Sera
Others
Global Cell Culture Reagents Market Revenue, by Type
Albumin
Human Serum Albumin (HSA)
Bovine Serum Albumin (BSA)
Recombinant Serum Albumin (RSA)
Amino Acids
Attachment Factors
Growth Factors & Cytokines
Insulin-like Growth Factors (IGF)
HumanKine Growth Factors and Cytokine
Tumor Necrosis Factor (TNF)
Others
Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others)
Others
Porcine Trypsin
Recombinant Trypsin
Thrombin
Miscellaneous Reagents
Global Cell Culture Media, Sera, and Reagents Market Revenue, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
India
Japan
Korea
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of Latin America
Rest of the World (RoW)
Israel
Russia
Rest of RoW

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. 

Global Tissue Engineered Skin Substitutes Market expected to reach USD 3.8 Billion in 2023

According to a new market research report published by Transparency Market Research “Tissue Engineered Skin Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023”, the global tissue engineered skin substitutes market was valued at USD 0.9 billion in 2014 and is estimated to reach USD 3.8 billion in 2023 expanding at a CAGR of 17.2% from 2015 to 2023.

Skin substitutes or artificial skin substitutes are derived from human tissue, non-human tissue, synthetic materials, and combination of the above materials. Tissue engineered skin substitutes are made up of cells, the extracellular matrix, and combination of cells and matrices. The tissue engineered skin substitutes market is growing at a significant pace due to rise in the number of diabetic and vascular ulcer patients, growing geriatric population, and increasing demand for minimally invasive surgical products. Moreover, growing medical tourism in regions such as Asia is likely to boost demand for tissue engineered skin substitutes. However, disease transmission and lack of favorable reimbursement could hamper market growth during the forecast period from 2015 to 2023. The global tissue engineered skin substitutes market was valued at USD 958.8 million in 2014 and is estimated to reach USD 3,873.5 million by 2023, expanding at a CAGR of 17.2% from 2015 to 2023.

Browse Full Report: http://www.transparencymarketresearch.com/tissue-engineered-skin-substitute.html

Based on type, the global tissue engineered skin substitutes market has been segmented into acellular, cellular allogeneic, cellular autologous, and others. Acellular skin substitute was the largest segment of the tissue engineered skin substitutes market in 2014 and is projected to expand at the highest CAGR from 2015 to 2023. This growth is majorly due to easy availability, low cost, and high demand for these products. Moreover, growing preference for acellular skin substitutes for implant-based skin surgery is likely to contribute to the growth of the segment. For instance, the American Society of Plastic Surgeons (2012) stated that more than 50% surgeons in the U.S. preferred acellular matrix for skin surgeries. Hence, growing preference for acellular skin substitutes boosts demand for tissue engineered skin substitutes. However, high risk of post-implementation infection associated with allogeneic skin substitutes is expected to restrict market growth.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3854

Based on application, the tissue engineered skin substitutes market has been segmented into burn injury, diabetic/vascular ulcer, and others. The diabetic and vascular ulcers segment held the largest share of the market in 2014 and is likely to expand at the highest CAGR during the forecast period due to rapid increase in the diabetic and vascular ulcer cases globally. For instance, according to International Diabetes Federation (2014), around 387 million people were diagnosed with diabetes across the world, and the number is expected to increase at a rapid pace. Skin substitutes are the ultimate choice for patients suffering from acute diabetic ulcers. Hence, escalating number of diabetic patients would fuel the growth of the tissue engineered skin substitutes market. However, lack of favorable reimbursement policies is expected to hamper market growth during the study period.

The global tissue engineered skin substitutes market is highly consolidated, with top four companies accounting for majority of the market share in 2014. Companies such as 3M Health Care, BSN medical, Medtronic, Acelity, L.P., Inc., Mölnlycke Health, and Integra LifeSciences Corporation are the key players operating in the global tissue engineered skin substitutes market.

Browse the full Tissue Engineered Skin Substitutes Market (by Type - Acellular, Cellular Allogeneic, Cellular Autologous, and Others; by Application - Burn Injury, Diabetic/Vascular Ulcer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/tissue-engineered-skin-substitute.html

The global tissue engineered skin substitutes market is segmented as follows:
Global Tissue Engineered Skin Substitutes Market, by Type

• Acellular
• Cellular Allogeneic
• Cellular Autologous
• Others

Global Tissue Engineered Skin Substitutes Market, by Application

• Burn Injury
• Diabetic/Vascular Ulcer
• Others

Global Tissue Engineered Skin Substitutes Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K
  • Germany
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Rest of APAC
• Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
• Middle East & Africa (MEA)
  • South Africa
  • Rest of MEA

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. 

Global Medical Imaging Equipment Market: X-ray Imaging Devices Constituted Largest Segment in 2014, Ultrasound Systems to Grow most Rapidly

According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com), titled “Medical Imaging Equipment Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2015 - 2023,” the global medical imaging equipment market was valued at US$27.7 billion in 2014 and is expected to reach US$45.3 bn by 2023, at a CAGR of 5.6% during the forecast period 2015 to 2023.

Rapid advances in radiology that have occurred in the past few decades have paved the way for the expansion of the medical imaging equipment market. Imaging devices such as magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have allowed further options for treatment guidance with low morbidity. This has helped physicians to assess patients without surgical intervention and thereby improve the patient outcomes and quality of life.

Browse Full Report: http://www.transparencymarketresearch.com/medical-imaging-equipment-market.html

X-ray imaging devices constituted the largest segment in the global medical imaging equipment market. The major driving factors for the growth of this segment include increasing incidence of disorders and easy availability and acceptability of x-ray devices. Rising incidence of cardiovascular, respiratory, oral, gastrointestinal, and genitourinary disorders are boosting reliance on several advanced x-ray diagnostic devices globally. The WHO estimates that around 60% to 90% of school children and 80% to 90% adults (aged 19 to 34 years) suffer from dental cavities. Moreover, the global incidence rate of oral cancer ranges between 1-10 cases per 100,000 individuals. These two factors, coupled with a large patient pool of patients suffering from dental cavities, will boost the global x-ray market. Among the x-ray devices segments, stationary devices dominated the market by virtue of being conventionally used imaging devices. These are also a more cost effective option compared to portable x-ray equipment devices. Stationary devices are mostly preferred in the underserved markets of Asia and Africa.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=105

Ultrasound systems are expected grow most rapidly during the forecast period owing to high adoption rates worldwide. Real-time image formation, higher safety and cost-effectiveness are some of the advantages of ultrasound imaging over MRI and CT scans, which currently drive the market. Earlier, the applications of these devices were more or less limited to abdomen imaging. However, the range of applications has broadened over time and they are now used to image the heart, kidneys, and other organs. Technologies applied in ultrasound imaging include 2-D imaging, 3-D and 4-D imaging, high intensity focused ultrasound (HIFU), lithotripsy and Doppler. Nuclear imaging devices are a recent development in the medical imaging equipment market, and are expected to witness high adoption by the end of forecast period from 2015 to 2023. As PET scanners are capable of detecting and recording a higher percentage of emitted rays, these devices are more efficient than the SPECT scanners and are thus expected to surpass the growth of SPECT scanners market.

Players such as Philips Healthcare, GE Healthcare, Siemens Healthcare, Hologic, Inc¸ Shimadzu Corporation, Samsung Medison Co. Ltd., Hitachi Medical Corporation, Genesis Medical Imaging, Inc., Carestream Health, Inc., Fujifilm Holdings Corporation, Fonar Corporation, and Toshiba Corporation. The global market has seen the dominance of a few leading players such as Philips Healthcare, GE Healthcare, Siemens Healthcare, and Toshiba Corporation.

Browse Full Medical Imaging Equipment Market (X-ray, Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Nuclear Imaging Equipment) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Report With Complete TOC @ http://www.transparencymarketresearch.com/medical-imaging-equipment-market.html

The global medical imaging equipment market is segmented into the following categories:
Medical Imaging Equipment Market, by Product

• X-Ray Devices
  • Stationary
  • Portable
• Ultrasound Systems
  • Cart/Trolley Based Ultrasound System
  • Compact/Portable Ultrasound System
• Computed Tomography (CT) Scanners
  • Stationary
  • Mobile
• Magnetic Resonance Imaging (MRI) Equipment
  • Closed
  • Open
• Nuclear Imaging Equipment
  • SPECT Scanner
  • PET Scanner

Medical Imaging Equipment Market, by Technology

• X-Ray Devices
  • Analog X-ray Technology
  • Digital Radiography
  • Computed Radiography
• Ultrasound Systems
  • 2-D
  • 3-D & 4-D
  • Doppler
  • High Intensity Frequency Ultrasound (HIFU)
  • Lithotripsy
• Computed Tomography (CT) Scanners
  • Stationary
  • Mobile
• Magnetic Resonance Imaging (MRI) Equipment
  • Low-Slice
  • Medium-Slice
  • High-Slice
• Nuclear Imaging Equipment
  • SPECT Scanner
  • PET Scanner

Medical Imaging Equipment Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East and Africa (MEA)
  • GCC Countries
  • Rest of MEA

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.